Analyst Reco. Mankind Pharma Limited

Equities

Delayed NSE India S.E. Other stock markets 09:46:57 13/03/2026 am IST			5-day change	1st Jan Change
2,189.00 ^INR	-0.86%		+0.16%	-0.27%

27/02	Mankind Pharma says tax penalty of 10.2 million rupees dropped	RE
16/02	Mankind Pharma says tax penalty of 4.6 million rupees dropped	RE

04/02	IIFL Downgrades Mankind Pharma to Add from Buy, Price Target is INR2,300	MT
07/11	Jefferies Adjusts Mankind Pharma's Price Target to INR3,000 From INR3,100, Keeps at Buy	MT
04/25/04	Reactions after India cuts consumption tax on hundreds of items	RE
04/25/04	Reactions after India cuts consumption tax on hundreds of items	RE
04/25/04	Jefferies Adjusts Mankind Pharma's Price Target to INR3,100 From INR3,000, Keeps at Buy	MT
11/25/11	Jefferies Adjusts Mankind Pharma's Price Target to INR3,000 From INR2,870, Keeps at Buy	MT
23/25/23	Jefferies Adjusts Mankind Pharma's Price Target to INR2,870 From INR3,300, Keeps at Buy	MT
27/25/27	Jefferies Adjusts Mankind Pharma's Price Target to INR3,300 From INR3,370, Keeps at Buy	MT
06/24/06	Jefferies Adjusts Mankind Pharma's Price Target to INR3,200 From INR2,430, Keeps at Buy	MT
01/23/01	Jefferies Adjusts Mankind Pharma's Price Target to INR1,850 From INR1,870, Keeps at Hold	MT
04/23/04	Jefferies Adjusts Mankind Pharma's Price Target to INR1,870 From INR1,830, Keeps at Hold	MT
03/23/03	INDIA STOCKS-Metals, realty lead fall in Indian shares tracking global slide	RE
02/23/02	Mankind Pharma Limited Announces Re-Designation of Mr. Suresh Raju Penmetsa as Chief Risk Officer	CI